Mabxience Holding, S.L., a prominent player in the biopharmaceutical industry, is headquartered in Spain and operates extensively across Europe and Latin America. Founded in 2015, the company has rapidly established itself as a leader in the development and manufacturing of biosimilars and innovative therapies, particularly in the fields of oncology and autoimmune diseases. Mabxience's core offerings include high-quality biosimilars that are distinguished by their rigorous development processes and commitment to patient safety. The company has achieved significant milestones, including successful product launches and partnerships that enhance its market position. With a focus on sustainability and innovation, Mabxience continues to make strides in improving patient access to essential treatments, solidifying its reputation as a trusted name in the biopharmaceutical sector.
We don't have data for Mabxience Holding, S.L., but we can show you information about their parent organization instead.
View parent company